Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 4/20 | 0.44 |
| ▸ | CSNK2B | P67870 | 4/20 | 0.44 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | TERT | O14746 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21865645 | 0.90 | CYP1B1 (0.46) | CSNK2A2CSNK2BCSNK2A1ABCB1ABCC1 | |
| SCHEMBL21886454 | 0.89 | ABCB1 (0.47) | CSNK2A2CSNK2BCSNK2A1ABCB1ABCC1 | |
| SCHEMBL21801153 | 0.86 | ABCB1 (0.53) | ABCB1ABCC1ABCG2CYP1A1CYP1B1 | |
| SCHEMBL30744133 | 0.83 | ABCB1 (0.58) | CSNK2A2CSNK2BCSNK2A1ABCB1ABCC1 | |
| SCHEMBL21801245 | 0.83 | ABCB1 (0.58) | CSNK2A2CSNK2BCSNK2A1ABCB1ABCC1 | |
| SCHEMBL21801308 | 0.82 | ABCB1 (0.52) | ABCB1ABCC1ABCG2CYP1A1CYP1B1 | |
| SCHEMBL21801155 | 0.82 | SIGMAR1 (0.41) | CSNK2A2CSNK2BCSNK2A1SIGMAR1 | |
| SCHEMBL21801157 | 0.82 | SIGMAR1 (0.41) | CSNK2A2CSNK2BCSNK2A1SIGMAR1 | |
| SCHEMBL30629641 | 0.82 | SIGMAR1 (0.41) | CSNK2A2CSNK2BCSNK2A1SIGMAR1 | |
| SCHEMBL21886510 | 0.79 | ABCC1 (0.47) | CSNK2A2CSNK2BCSNK2A1ABCB1ABCC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020053249-A1 | FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2020-03-19 | — | — | WO | disclosed |